Aller au contenu principal
Profil bibliographique

Kai Funakawa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
88Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Parkinson's Disease Mechanisms and TreatmentsCellular transport and secretionLysosomal Storage Disorders ResearchDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Les publications récentes

Accès ouvert 2026 article OpenAlex

Early-onset Alzheimer’s disease with PSEN1 G206D mutation presenting with amnesia at an onset age of 29 years old

Kai Funakawa, Masanori Kurihara, Kensuke Takahashi, Ryoko Ihara et autres

The patient was a 36-year-old woman with normal birth and development. The patient experienced gradual memory loss from the age of 29 years old. The patient showed irritability at 35, convulsion at 36, and was diagnosed to have early-onset dementia. Family history …

jp (code pays fourni par la source)

0 citations Rinsho Shinkeigaku
Accès ouvert 2020 article OpenAlex

Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation

Tomoki Kuwahara, Kai Funakawa, Tadayuki Komori, Maria Sakurai et autres

Leucine-rich repeat kinase 2 (LRRK2), the major causative gene product of autosomal-dominant Parkinson's disease, is a protein kinase that phosphorylates a subset of Rab GTPases. Since pathogenic LRRK2 mutations increase its ability to phosphorylate Rab GTPases, elucidating the mechanisms of how Rab …

jp (code pays fourni par la source)

80 citations Neurobiology of Disease
Accès ouvert 2020 preprint OpenAlex

Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation

Tomoki Kuwahara, Kai Funakawa, Tadayuki Komori, Maria Sakurai et autres

Abstract Leucine-rich repeat kinase 2 (LRRK2), the major causative gene product of autosomal-dominant Parkinson’s disease, is a protein kinase that phosphorylates a subset of Rab GTPases. Since pathogenic LRRK2 mutations increase its ability to phosphorylate Rab GTPases, elucidating the mechanisms of how …

jp (code pays fourni par la source)

6 citations bioRxiv (Cold Spring Harbor Laboratory)
2011 conference-abstract OpenAlex

Therapeutic strategies for intestinal Behçet's disease

Hiroshi Fujita, Fumisato Sasaki, Hitoshi Setoyama, Kai Funakawa et autres

Intestinal Behçet's disease (BD) is typically characterized by intestinal inflammation with discrete round or oval-shaped ulcers which are highly associated with gastrointestinal manifestations. Intestinal BD occasionally causes serious morbidity, such as gastrointestinal bleeding and perforation, and has a high postoperative recurrence rate. …

jp (code pays fourni par la source)

0 citations Inflammatory Bowel Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.